The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd

Ownership Changes View source PDF Explain this filing

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹238.10

prior close

₹236.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+1.9% vs market

Pharmaceuticals peers, median of 151sector+0.2%+1.8% vs sector

On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.2

10m

+2.8

15m

+2.8

30m

+2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0+0.1+1.9+0.2+1.8

Next day

+2.4+0.5+1.9+0.8+1.6

+1.6-0.0+1.6+0.2+1.4

+0.8-0.1+0.9+0.0+0.8

-0.5+0.4-0.8+0.1-0.6

-0.8+0.7-1.5-0.2-0.6

-0.3+0.4-0.7+0.3-0.5

15d

+0.0+1.1-1.0+0.5-0.4

-4.7-2.0-2.7-1.4-3.3

-1.3-1.9+0.5-3.2+1.9

+12.6-2.7+15.3-3.7+16.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BSE has received a disclosure under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011, filed by Vistra ITCL (India) Ltd, which acts as a trustee/ custodian for shares of SMS Pharmaceuticals. Regulation 29(2) disclosures typically relate to encumbrance (pledge) of shares held by promoters or promoter group entities. The available filing does not specify whether this is a creation, invocation, or release of pledge, nor the quantum of shares involved.

Likely market impact

The headline alone is not enough to determine any meaningful impact on shareholders. Investors should check the detailed disclosure for the nature and size of the encumbrance change before drawing any conclusions.